rewirebio.iobenchmarks
Dataset

Zeng et al. 2026 primary paired-end cfMeDIP-seq dataset (420 samples)

Paired-end cfMeDIP-seq baseline samples of the TCGE studies used for classifier training and cross-validation, LFS cases excluded.

Evaluation results

10 evaluations · 20 results. Different protocols are not a single leaderboard.

Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: Zeng et al. 2026 classifier: Combined All Features (1%)Protocol: Zeng et al. 2026 primary PE dataset: cancer vs healthy, nested cross-validation
Dataset: Zeng et al. 2026 primary paired-end cfMeDIP-seq dataset (420 samples)
0.97 AUROC (cancer vs healthy, primary PE dataset, mean over 10 fold models)
unitless · higher

Uncertainty: SD 0.0227978278651072. Figure 4 legend: error bars in a, c, e and g are ±1 s.d. across cross-validation folds (n = 10).

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Combined All Features (1%) on pe primary cv (Zeng et al. 2026)

ctdnalit-20261011-zeng2026-protocol-pe-primary-cv

Aggregation: Not reported

A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4a, row 2 'Combined All Features (1%)', column B 'mean_auc'
Configuration: Zeng et al. 2026 classifier: Combined All Features (1%)Protocol: Zeng et al. 2026 primary PE dataset: cancer vs healthy, nested cross-validation
Dataset: Zeng et al. 2026 primary paired-end cfMeDIP-seq dataset (420 samples)
0.86 Sensitivity at 99% specificity (cancer vs healthy, primary PE dataset, mean over 10 fold models)
fraction · higher

Uncertainty: ± 0.0981509647480165 (type not stated). Source Data columns are headed sd_sens99 and the sheets' text column prints 'Sensitivity=x ± y'; the Figure 4 legend says the error bars in panels b, d, f and h are s.e. Methods P61 says error bars denote across-fold s.d.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Combined All Features (1%) on pe primary cv (Zeng et al. 2026)

ctdnalit-20261011-zeng2026-protocol-pe-primary-cv

Aggregation: Not reported

A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4b, row 2 'Combined All Features (1%)', column B 'mean_sens99'
Configuration: Zeng et al. 2026 classifier: Combined All Features (5%)Protocol: Zeng et al. 2026 primary PE dataset: cancer vs healthy, nested cross-validation
Dataset: Zeng et al. 2026 primary paired-end cfMeDIP-seq dataset (420 samples)
0.932 AUROC (cancer vs healthy, primary PE dataset, mean over 10 fold models)
unitless · higher

Uncertainty: SD 0.0424929753478305. Figure 4 legend: error bars in a, c, e and g are ±1 s.d. across cross-validation folds (n = 10).

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Combined All Features (5%) on pe primary cv (Zeng et al. 2026)

ctdnalit-20261011-zeng2026-protocol-pe-primary-cv

Aggregation: Not reported

A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4a, row 3 'Combined All Features (5%)', column B 'mean_auc'
Configuration: Zeng et al. 2026 classifier: Combined All Features (5%)Protocol: Zeng et al. 2026 primary PE dataset: cancer vs healthy, nested cross-validation
Dataset: Zeng et al. 2026 primary paired-end cfMeDIP-seq dataset (420 samples)
0.789 Sensitivity at 99% specificity (cancer vs healthy, primary PE dataset, mean over 10 fold models)
fraction · higher

Uncertainty: ± 0.107405582907328 (type not stated). Source Data columns are headed sd_sens99 and the sheets' text column prints 'Sensitivity=x ± y'; the Figure 4 legend says the error bars in panels b, d, f and h are s.e. Methods P61 says error bars denote across-fold s.d.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Combined All Features (5%) on pe primary cv (Zeng et al. 2026)

ctdnalit-20261011-zeng2026-protocol-pe-primary-cv

Aggregation: Not reported

A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4b, row 3 'Combined All Features (5%)', column B 'mean_sens99'
Configuration: Zeng et al. 2026 classifier: End MotifsProtocol: Zeng et al. 2026 primary PE dataset: cancer vs healthy, nested cross-validation
Dataset: Zeng et al. 2026 primary paired-end cfMeDIP-seq dataset (420 samples)
0.93 AUROC (cancer vs healthy, primary PE dataset, mean over 10 fold models)
unitless · higher

Uncertainty: SD 0.0519161667413912. Figure 4 legend: error bars in a, c, e and g are ±1 s.d. across cross-validation folds (n = 10).

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

End Motifs on pe primary cv (Zeng et al. 2026)

ctdnalit-20261011-zeng2026-protocol-pe-primary-cv

Aggregation: Not reported

A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4a, row 7 'End Motifs', column B 'mean_auc'
Configuration: Zeng et al. 2026 classifier: End MotifsProtocol: Zeng et al. 2026 primary PE dataset: cancer vs healthy, nested cross-validation
Dataset: Zeng et al. 2026 primary paired-end cfMeDIP-seq dataset (420 samples)
0.826 Sensitivity at 99% specificity (cancer vs healthy, primary PE dataset, mean over 10 fold models)
fraction · higher

Uncertainty: ± 0.136261133071318 (type not stated). Source Data columns are headed sd_sens99 and the sheets' text column prints 'Sensitivity=x ± y'; the Figure 4 legend says the error bars in panels b, d, f and h are s.e. Methods P61 says error bars denote across-fold s.d.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

End Motifs on pe primary cv (Zeng et al. 2026)

ctdnalit-20261011-zeng2026-protocol-pe-primary-cv

Aggregation: Not reported

A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4b, row 7 'End Motifs', column B 'mean_sens99'
Configuration: Zeng et al. 2026 classifier: Fragment RatioProtocol: Zeng et al. 2026 primary PE dataset: cancer vs healthy, nested cross-validation
Dataset: Zeng et al. 2026 primary paired-end cfMeDIP-seq dataset (420 samples)
0.923 AUROC (cancer vs healthy, primary PE dataset, mean over 10 fold models)
unitless · higher

Uncertainty: SD 0.0705965005812822. Figure 4 legend: error bars in a, c, e and g are ±1 s.d. across cross-validation folds (n = 10).

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Fragment Ratio on pe primary cv (Zeng et al. 2026)

ctdnalit-20261011-zeng2026-protocol-pe-primary-cv

Aggregation: Not reported

A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4a, row 8 'Fragment Ratio', column B 'mean_auc'
Configuration: Zeng et al. 2026 classifier: Fragment RatioProtocol: Zeng et al. 2026 primary PE dataset: cancer vs healthy, nested cross-validation
Dataset: Zeng et al. 2026 primary paired-end cfMeDIP-seq dataset (420 samples)
0.795 Sensitivity at 99% specificity (cancer vs healthy, primary PE dataset, mean over 10 fold models)
fraction · higher

Uncertainty: ± 0.193024274189439 (type not stated). Source Data columns are headed sd_sens99 and the sheets' text column prints 'Sensitivity=x ± y'; the Figure 4 legend says the error bars in panels b, d, f and h are s.e. Methods P61 says error bars denote across-fold s.d.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Fragment Ratio on pe primary cv (Zeng et al. 2026)

ctdnalit-20261011-zeng2026-protocol-pe-primary-cv

Aggregation: Not reported

A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4b, row 8 'Fragment Ratio', column B 'mean_sens99'
Configuration: Zeng et al. 2026 classifier: Insert SizeProtocol: Zeng et al. 2026 primary PE dataset: cancer vs healthy, nested cross-validation
Dataset: Zeng et al. 2026 primary paired-end cfMeDIP-seq dataset (420 samples)
0.748 AUROC (cancer vs healthy, primary PE dataset, mean over 10 fold models)
unitless · higher

Uncertainty: SD 0.0974579710205907. Figure 4 legend: error bars in a, c, e and g are ±1 s.d. across cross-validation folds (n = 10).

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Insert Size on pe primary cv (Zeng et al. 2026)

ctdnalit-20261011-zeng2026-protocol-pe-primary-cv

Aggregation: Not reported

A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4a, row 9 'Insert Size', column B 'mean_auc'
Configuration: Zeng et al. 2026 classifier: Insert SizeProtocol: Zeng et al. 2026 primary PE dataset: cancer vs healthy, nested cross-validation
Dataset: Zeng et al. 2026 primary paired-end cfMeDIP-seq dataset (420 samples)
0.283 Sensitivity at 99% specificity (cancer vs healthy, primary PE dataset, mean over 10 fold models)
fraction · higher

Uncertainty: ± 0.19494005154084 (type not stated). Source Data columns are headed sd_sens99 and the sheets' text column prints 'Sensitivity=x ± y'; the Figure 4 legend says the error bars in panels b, d, f and h are s.e. Methods P61 says error bars denote across-fold s.d.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Insert Size on pe primary cv (Zeng et al. 2026)

ctdnalit-20261011-zeng2026-protocol-pe-primary-cv

Aggregation: Not reported

A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4b, row 9 'Insert Size', column B 'mean_sens99'
Configuration: Zeng et al. 2026 classifier: MethylationProtocol: Zeng et al. 2026 primary PE dataset: cancer vs healthy, nested cross-validation
Dataset: Zeng et al. 2026 primary paired-end cfMeDIP-seq dataset (420 samples)
0.986 AUROC (cancer vs healthy, primary PE dataset, mean over 10 fold models)
unitless · higher

Uncertainty: SD 0.0209780603284754. Figure 4 legend: error bars in a, c, e and g are ±1 s.d. across cross-validation folds (n = 10).

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Methylation on pe primary cv (Zeng et al. 2026)

ctdnalit-20261011-zeng2026-protocol-pe-primary-cv

Aggregation: Not reported

A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4a, row 10 'Methylation', column B 'mean_auc'
Configuration: Zeng et al. 2026 classifier: MethylationProtocol: Zeng et al. 2026 primary PE dataset: cancer vs healthy, nested cross-validation
Dataset: Zeng et al. 2026 primary paired-end cfMeDIP-seq dataset (420 samples)
0.949 Sensitivity at 99% specificity (cancer vs healthy, primary PE dataset, mean over 10 fold models)
fraction · higher

Uncertainty: ± 0.0870136746761039 (type not stated). Source Data columns are headed sd_sens99 and the sheets' text column prints 'Sensitivity=x ± y'; the Figure 4 legend says the error bars in panels b, d, f and h are s.e. Methods P61 says error bars denote across-fold s.d.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Methylation on pe primary cv (Zeng et al. 2026)

ctdnalit-20261011-zeng2026-protocol-pe-primary-cv

Aggregation: Not reported

A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4b, row 10 'Methylation', column B 'mean_sens99'
Configuration: Zeng et al. 2026 classifier: Combined Motif + Methylation (1%)Protocol: Zeng et al. 2026 primary PE dataset: cancer vs healthy, nested cross-validation
Dataset: Zeng et al. 2026 primary paired-end cfMeDIP-seq dataset (420 samples)
0.938 AUROC (cancer vs healthy, primary PE dataset, mean over 10 fold models)
unitless · higher

Uncertainty: SD 0.0401311333432108. Figure 4 legend: error bars in a, c, e and g are ±1 s.d. across cross-validation folds (n = 10).

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Combined Motif + Methylation (1%) on pe primary cv (Zeng et al. 2026)

ctdnalit-20261011-zeng2026-protocol-pe-primary-cv

Aggregation: Not reported

A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4a, row 4 'Combined Motif + Methylation (1%)', column B 'mean_auc'
Configuration: Zeng et al. 2026 classifier: Combined Motif + Methylation (1%)Protocol: Zeng et al. 2026 primary PE dataset: cancer vs healthy, nested cross-validation
Dataset: Zeng et al. 2026 primary paired-end cfMeDIP-seq dataset (420 samples)
0.773 Sensitivity at 99% specificity (cancer vs healthy, primary PE dataset, mean over 10 fold models)
fraction · higher

Uncertainty: ± 0.14899523978531 (type not stated). Source Data columns are headed sd_sens99 and the sheets' text column prints 'Sensitivity=x ± y'; the Figure 4 legend says the error bars in panels b, d, f and h are s.e. Methods P61 says error bars denote across-fold s.d.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Combined Motif + Methylation (1%) on pe primary cv (Zeng et al. 2026)

ctdnalit-20261011-zeng2026-protocol-pe-primary-cv

Aggregation: Not reported

A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4b, row 4 'Combined Motif + Methylation (1%)', column B 'mean_sens99'
Configuration: Zeng et al. 2026 classifier: Combined Motif + Methylation + Ratios (1%)Protocol: Zeng et al. 2026 primary PE dataset: cancer vs healthy, nested cross-validation
Dataset: Zeng et al. 2026 primary paired-end cfMeDIP-seq dataset (420 samples)
0.974 AUROC (cancer vs healthy, primary PE dataset, mean over 10 fold models)
unitless · higher

Uncertainty: SD 0.0242400530902103. Figure 4 legend: error bars in a, c, e and g are ±1 s.d. across cross-validation folds (n = 10).

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Combined Motif + Methylation + Ratios (1%) on pe primary cv (Zeng et al. 2026)

ctdnalit-20261011-zeng2026-protocol-pe-primary-cv

Aggregation: Not reported

A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4a, row 5 'Combined Motif + Methylation + Ratios (1%)', column B 'mean_auc'
Configuration: Zeng et al. 2026 classifier: Combined Motif + Methylation + Ratios (1%)Protocol: Zeng et al. 2026 primary PE dataset: cancer vs healthy, nested cross-validation
Dataset: Zeng et al. 2026 primary paired-end cfMeDIP-seq dataset (420 samples)
0.896 Sensitivity at 99% specificity (cancer vs healthy, primary PE dataset, mean over 10 fold models)
fraction · higher

Uncertainty: ± 0.0857671794470052 (type not stated). Source Data columns are headed sd_sens99 and the sheets' text column prints 'Sensitivity=x ± y'; the Figure 4 legend says the error bars in panels b, d, f and h are s.e. Methods P61 says error bars denote across-fold s.d.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Combined Motif + Methylation + Ratios (1%) on pe primary cv (Zeng et al. 2026)

ctdnalit-20261011-zeng2026-protocol-pe-primary-cv

Aggregation: Not reported

A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4b, row 5 'Combined Motif + Methylation + Ratios (1%)', column B 'mean_sens99'
Configuration: Zeng et al. 2026 classifier: Nucleosome PeakProtocol: Zeng et al. 2026 primary PE dataset: cancer vs healthy, nested cross-validation
Dataset: Zeng et al. 2026 primary paired-end cfMeDIP-seq dataset (420 samples)
0.689 AUROC (cancer vs healthy, primary PE dataset, mean over 10 fold models)
unitless · higher

Uncertainty: SD 0.1141088789247. Figure 4 legend: error bars in a, c, e and g are ±1 s.d. across cross-validation folds (n = 10).

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Nucleosome Peak on pe primary cv (Zeng et al. 2026)

ctdnalit-20261011-zeng2026-protocol-pe-primary-cv

Aggregation: Not reported

A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4a, row 11 'Nucleosome Peak', column B 'mean_auc'
Configuration: Zeng et al. 2026 classifier: Nucleosome PeakProtocol: Zeng et al. 2026 primary PE dataset: cancer vs healthy, nested cross-validation
Dataset: Zeng et al. 2026 primary paired-end cfMeDIP-seq dataset (420 samples)
0.397 Sensitivity at 99% specificity (cancer vs healthy, primary PE dataset, mean over 10 fold models)
fraction · higher

Uncertainty: ± 0.143496781034909 (type not stated). Source Data columns are headed sd_sens99 and the sheets' text column prints 'Sensitivity=x ± y'; the Figure 4 legend says the error bars in panels b, d, f and h are s.e. Methods P61 says error bars denote across-fold s.d.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Nucleosome Peak on pe primary cv (Zeng et al. 2026)

ctdnalit-20261011-zeng2026-protocol-pe-primary-cv

Aggregation: Not reported

A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4b, row 11 'Nucleosome Peak', column B 'mean_sens99'
Configuration: Zeng et al. 2026 classifier: Combined Ratios + Methylation (1%)Protocol: Zeng et al. 2026 primary PE dataset: cancer vs healthy, nested cross-validation
Dataset: Zeng et al. 2026 primary paired-end cfMeDIP-seq dataset (420 samples)
0.961 AUROC (cancer vs healthy, primary PE dataset, mean over 10 fold models)
unitless · higher

Uncertainty: SD 0.0300613681834156. Figure 4 legend: error bars in a, c, e and g are ±1 s.d. across cross-validation folds (n = 10).

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Combined Ratios + Methylation (1%) on pe primary cv (Zeng et al. 2026)

ctdnalit-20261011-zeng2026-protocol-pe-primary-cv

Aggregation: Not reported

A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4a, row 6 'Combined Ratios + Methylation (1%)', column B 'mean_auc'
Configuration: Zeng et al. 2026 classifier: Combined Ratios + Methylation (1%)Protocol: Zeng et al. 2026 primary PE dataset: cancer vs healthy, nested cross-validation
Dataset: Zeng et al. 2026 primary paired-end cfMeDIP-seq dataset (420 samples)
0.857 Sensitivity at 99% specificity (cancer vs healthy, primary PE dataset, mean over 10 fold models)
fraction · higher

Uncertainty: ± 0.0828537049838524 (type not stated). Source Data columns are headed sd_sens99 and the sheets' text column prints 'Sensitivity=x ± y'; the Figure 4 legend says the error bars in panels b, d, f and h are s.e. Methods P61 says error bars denote across-fold s.d.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Combined Ratios + Methylation (1%) on pe primary cv (Zeng et al. 2026)

ctdnalit-20261011-zeng2026-protocol-pe-primary-cv

Aggregation: Not reported

A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection; Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries) · Source Data Fig. 4, sheet Fig.4b, row 6 'Combined Ratios + Methylation (1%)', column B 'mean_sens99'

Source checking is not independent reproduction. Release 2026-11-21-c8bea25e5abb.

Research readiness

0 of 4 readiness checks met. These checks assess whether the evidence supports a reproducible investigation; a source-checked score alone does not meet them.

Readiness checks, gaps and artifacts

Release 2026-11-21-c8bea25e5abb · Evidence verified: Not verified

Evidence incomplete

Replay metrics

Exact outcomes, predictions, identifiers and evaluator are connected.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Metrics are recomputed from the saved predictions: not yet verified

Verified: Not verified

Evidence incomplete

Investigate discrepancies

Replay evidence includes annotations and an assessment of dependence. Unknown independence permits descriptive analysis only.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Metrics are recomputed from the saved predictions: not yet verified
  • Sample annotations are recorded: not yet verified
  • Dependence between samples is assessed: not yet verified

Verified: Not verified

Evidence incomplete

Run locally

A pinned recipe describes the inputs, environment and resource requirements.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • A pinned run recipe exists: not yet verified
  • Compute requirements are estimated: not yet verified

Verified: Not verified

Evidence incomplete

Validate independently

Separate data and exposure records support an independent test.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Independent validation data exist: not yet verified
  • Overlap with training data is checked: not yet verified

Verified: Not verified

Readiness describes the evidence in this release. Availability on your computer is checked separately when an investigation runs. Existing data exposure can prevent independent validation even when files are available.

Artifacts and reproduction

No verified artifact manifest is connected to this record yet. The gaps above identify what is needed before analysis can begin.

Dataset and evaluation context

A dataset supplies biological observations. The evaluation protocol defines how those observations are split, used and scored.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

20 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-11-21-c8bea25e5abb
Property and statementOriginal source and locationReview and provenance
Assay
cfMeDIP-seq, paired-end
Context-only references
A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection

Original source ↗

Extended Data Fig. 7b and Fig. 9 legends; Results P29; Methods P59-P62

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Nature Cancer, published online 2026-02-19; Europe PMC full-text JATS XML of PMC12948677
Retrieved: 2026-10-11T21:40:43Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.assay

Source artifact SHA-256: 72e823206c332b5e7649e813e130e9d5122d202bac56cbcc55358b81e761e323

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Assay
cfMeDIP-seq, paired-end
Context-only references
Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries)

Original source ↗

Extended Data Fig. 7b and Fig. 9 legends; Results P29; Methods P59-P62

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 43018_2026_1116_MOESM6_ESM.xlsx (Source Data Fig. 4), publisher supplementary file
Retrieved: 2026-10-11T21:41:25Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.assay

Source artifact SHA-256: fae751686bbe1a15c5e1e2312b8679afd235a97b305b56f925744788ab0163b4

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Negatives
64
Context-only references
A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection

Original source ↗

Extended Data Fig. 7b and Fig. 9 legends; Results P29; Methods P59-P62

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Nature Cancer, published online 2026-02-19; Europe PMC full-text JATS XML of PMC12948677
Retrieved: 2026-10-11T21:40:43Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.negatives

Source artifact SHA-256: 72e823206c332b5e7649e813e130e9d5122d202bac56cbcc55358b81e761e323

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Negatives
64
Context-only references
Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries)

Original source ↗

Extended Data Fig. 7b and Fig. 9 legends; Results P29; Methods P59-P62

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 43018_2026_1116_MOESM6_ESM.xlsx (Source Data Fig. 4), publisher supplementary file
Retrieved: 2026-10-11T21:41:25Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.negatives

Source artifact SHA-256: fae751686bbe1a15c5e1e2312b8679afd235a97b305b56f925744788ab0163b4

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Population
356 cancers (AML 5, lung 59, uveal melanoma 10, prostate 97, head and neck 33, brain 152) and 64 healthy controls
Context-only references
A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection

Original source ↗

Extended Data Fig. 7b and Fig. 9 legends; Results P29; Methods P59-P62

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Nature Cancer, published online 2026-02-19; Europe PMC full-text JATS XML of PMC12948677
Retrieved: 2026-10-11T21:40:43Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.population

Source artifact SHA-256: 72e823206c332b5e7649e813e130e9d5122d202bac56cbcc55358b81e761e323

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Population
356 cancers (AML 5, lung 59, uveal melanoma 10, prostate 97, head and neck 33, brain 152) and 64 healthy controls
Context-only references
Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries)

Original source ↗

Extended Data Fig. 7b and Fig. 9 legends; Results P29; Methods P59-P62

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 43018_2026_1116_MOESM6_ESM.xlsx (Source Data Fig. 4), publisher supplementary file
Retrieved: 2026-10-11T21:41:25Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.population

Source artifact SHA-256: fae751686bbe1a15c5e1e2312b8679afd235a97b305b56f925744788ab0163b4

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Positives
356
Context-only references
A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection

Original source ↗

Extended Data Fig. 7b and Fig. 9 legends; Results P29; Methods P59-P62

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Nature Cancer, published online 2026-02-19; Europe PMC full-text JATS XML of PMC12948677
Retrieved: 2026-10-11T21:40:43Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.positives

Source artifact SHA-256: 72e823206c332b5e7649e813e130e9d5122d202bac56cbcc55358b81e761e323

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Positives
356
Context-only references
Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries)

Original source ↗

Extended Data Fig. 7b and Fig. 9 legends; Results P29; Methods P59-P62

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 43018_2026_1116_MOESM6_ESM.xlsx (Source Data Fig. 4), publisher supplementary file
Retrieved: 2026-10-11T21:41:25Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.positives

Source artifact SHA-256: fae751686bbe1a15c5e1e2312b8679afd235a97b305b56f925744788ab0163b4

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Scope note
cfMeDIP-seq of baseline plasma samples from The Cancer Genetics and Epigenetics (TCGE) studies, processed with MEDIPIPE and normalised with ComBat-seq and DESeq2 separately for paired-end (PE) and single-end (SE) data. Clinically diagnosed cancers and healthy donors; not a screening population.
Context-only references
A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection

Original source ↗

Extended Data Fig. 7b and Fig. 9 legends; Results P29; Methods P59-P62

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Nature Cancer, published online 2026-02-19; Europe PMC full-text JATS XML of PMC12948677
Retrieved: 2026-10-11T21:40:43Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.scope_note

Source artifact SHA-256: 72e823206c332b5e7649e813e130e9d5122d202bac56cbcc55358b81e761e323

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Scope note
cfMeDIP-seq of baseline plasma samples from The Cancer Genetics and Epigenetics (TCGE) studies, processed with MEDIPIPE and normalised with ComBat-seq and DESeq2 separately for paired-end (PE) and single-end (SE) data. Clinically diagnosed cancers and healthy donors; not a screening population.
Context-only references
Zeng et al. 2026, Source Data Fig. 4 (classifier AUC and sensitivity summaries)

Original source ↗

Extended Data Fig. 7b and Fig. 9 legends; Results P29; Methods P59-P62

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 43018_2026_1116_MOESM6_ESM.xlsx (Source Data Fig. 4), publisher supplementary file
Retrieved: 2026-10-11T21:41:25Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.scope_note

Source artifact SHA-256: fae751686bbe1a15c5e1e2312b8679afd235a97b305b56f925744788ab0163b4

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

How to read the evidence

Sources and history

Release 2026-11-21-c8bea25e5abb · Record review: source checked

2 source records and release historyDownload this release (gzip)
Technical metadata and record identifiers

Technical metadata for this record is tracked under stable ID ctdnalit-20261011-zeng2026-data-pe-primary.

Source locator: Extended Data Fig. 7b and Fig. 9 legends; Results P29; Methods P59-P62

Related records

Suggest a correction